Psychosocial needs and responses for breast cancer patients during COVID‐19 pandemic in a hospital of Southern Europe

Tekijä Illarramendi, Jose Juan, Arraras, Juan Ignacio, Zarandona, Uxue
Julkaisussa Psychooncology (2020)

P002: Clinical Correlates of Impaired Fatigue Scores in Quality-of-Life Evaluation for Long-Term Survivors of Breast Cancer

Tekijä Illarramendi, Jose Juan, Arrarás, Juan Ignacio, Zarandona, Uxue, Salgado, Esteban, De La Cruz, Susana, de Lascoiti, Angela Fernández, Lainez, Nuria, Vera, Ruth
Julkaistu 2012

P003: Association of Fatigue with Other Tested Scales in EORTC Quality-of-Life Questionnaires for Breast Cancer Survivors

Tekijä Illarramendi, Jose Juan, Arraras, Juan Ignacio, Zarandona, Uxue, Salgado, Esteban, De La Cruz, Susana, de Lascoiti, Angela Fernández, Lainez, Nuria, Vera, Ruth
Julkaistu 2012

Quality of Life in Spanish advanced non-small-cell lung cancer patients: determinants of global QL and survival analyses

Tekijä Arraras, Juan Ignacio, Hernandez, Berta, Martinez, Maite, Cambra, Koldo, Rico, Mikel, Illarramendi, Jose Juan, Viudez, Antonio, Ibañez, Berta, Zarandona, Uxue, Martinez, Enrique, Vera, Ruth
Julkaisussa Springerplus (2016)

An evaluation study of the determinants of future perspective and global Quality of Life in Spanish long-term premenopausal early-stage breast cancer survivors

Tekijä Arraras, Juan Ignacio, Illarramendi, Jose Juan, Salgado, Esteban, de la Cruz, Susana, Asin, Gemma, Manterola, Ana, Ibañez, Berta, Zarandona, Uxue, Dominguez, Miguel Angel, Vera, Ruth
Julkaisussa Contemp Oncol (Pozn) (2016)

Early Imaging and Molecular Changes with Neoadjuvant Bevacizumab in Stage II/III Breast Cancer

Tekijä López-Vega, José Manuel, Álvarez, Isabel, Antón, Antonio, Illarramendi, José Juan, Llombart, Antonio, Boni, Valentina, García-Velloso, María José, Martí-Climent, Josep María, Pina, Luis, García-Foncillas, Jesús
Julkaisussa Cancers (Basel) (2021)

CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer

Tekijä Martín-Sánchez, Esperanza, Mendaza, Saioa, Ulazia-Garmendia, Ane, Monreal-Santesteban, Iñaki, Blanco-Luquin, Idoia, Córdoba, Alicia, Vicente-García, Francisco, Pérez-Janices, Noemí, Escors, David, Megías, Diego, López-Serra, Paula, Esteller, Manel, Illarramendi, José Juan, Guerrero-Setas, David
Julkaisussa Oncotarget (2017)

Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis

Tekijä Perez-Janices, Noemi, Blanco-Luquin, Idoia, Torrea, Natalia, Liechtenstein, Therese, Escors, David, Cordoba, Alicia, Vicente-Garcia, Francisco, Jauregui, Isabel, De La Cruz, Susana, Illarramendi, José Juan, Coca, Valle, Berdasco, Maria, Kochan, Grazyna, Ibañez, Berta, Lera, José Miguel, Guerrero-Setas, David
Julkaisussa Oncotarget (2015)

Broad consensus on the optimal sequence for the systemic treatment of metastatic breast cancer: results from a survey of Spanish medical oncologists

Tekijä Sánchez-Rovira, Pedro, Zamora, Pilar, Salvador-Bofill, Javier, Morales, Serafín, Martínez-Jáñez, Noelia, Martínez-de-Dueñas, Eduardo, Lluch, Ana, Illarramendi, José Juan, Gómez-Pardo, Patricia, Gavilá Gregori, Joaquín, García-Palomo, Andrés, García-Mata, Jesús, Fernández, Yolanda, del Barco, Sonia, de Juan, Ana, Ciruelos, Eva, Chacón, José Ignacio, Calvo, Lourdes, Barnadas, Agustí, Albanell, Joan
Julkaisussa J Drug Assess (2019)